Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000437222

Medchemexpress LLC T025 | 2407433-00-3 | 99.6% | 382.42 | 10 MG
SDP

Catalog No. 5000437222
Encompass_Preferred

T025 is an orally active and highly potent inhibitor of Cdc2-like kinase (CLKs). It induces caspase-3/7-mediated cell apoptosis, reduces CLK-dependent phosphorylation, and exhibits anti-proliferative activities in hematological and solid cancer cell lines. T025 primarily has anti-tumor efficiency for MYC-driven disease research.

  • Orally active and highly potent inhibitor of Cdc2-like kinase (CLKs)
  • Induces caspase-3/7-mediated cell apoptosis
  • Reduces CLK-dependent phosphorylation
  • Exhibits anti-proliferative activities in hematological and solid cancer cell lines
  • Anti-tumor efficiency for MYC-driven disease research

Catalog No. 50-004-37222 Supplier Medchemexpress LLC Supplier No. HY11229610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

T025 is an orally active and highly potent inhibitor of Cdc2-like kinase (CLKs). It induces caspase-3/7-mediated cell apoptosis, reduces CLK-dependent phosphorylation, and exhibits anti-proliferative activities in hematological and solid cancer cell lines. T025 primarily has anti-tumor efficiency for MYC-driven disease research.

  • Orally active and highly potent inhibitor of Cdc2-like kinase (CLKs)
  • Induces caspase-3/7-mediated cell apoptosis
  • Reduces CLK-dependent phosphorylation
  • Exhibits anti-proliferative activities in hematological and solid cancer cell lines
  • Anti-tumor efficiency for MYC-driven disease research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.